Skip to main content
SpringerLink
Log in

Mechanistic Evidence to Support the Anti-hepatitis B Viral Activity of Multifunctional Scaffold & Conformationally Restricted Magnolol

  • Research Article
  • Published:
National Academy Science Letters Aims and scope Submit manuscript

Abstract

Magnolol, phenolic bioactive phytomolecule, is a potential antihepatitis B viral agent. Current study is to mechanistically analyze the probable site of action for magnolol. Magnolol has been docked with EF3-CaM adenylyl cyclase (1PK0), deoxycytidine kinase (2NOA), human nucleoside diphosphate kinase (3FKB), human hepatitis B viral capsid (1QGT), hepatitis B X-interacting protein (3MSH) proteins using GRIP docking methodology, and compared with reference ligands like adefovir diphosphate (active metabolite of adefovir), lamivudine, tenofovir monophosphate (active metabolite of tenofovir) and tenofovir diphosphate (active metabolite of tenofovir). Results revealed its preferential interactability towards 2NOA i.e. deoxycytidine kinase, which raise up its chance to get metabolized into phosphorylated analogs, providing further impetus for discovery and clinical development of semi-synthetic analogs of magnolol. Out of all the virtually designed magnolol derivatives, Leadgrow_ML1449 have superior binding affinities towards all the test proteins except EF3-CaM adenylyl cyclase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Attrey DP, Singh AK, Katyal J et al (2012) Pharmacognostical characterization & preliminary phytochemical investigation of seabuckthorn (Hippophae rhamnoides L.) leaves. Indo Global J Pharm Sci 2(2):108–113

    Google Scholar 

  2. Antonelli G, Turriziani O (2012) Antiviral therapy: old and current issues. Int J Antimicrob Agents 40:95–102

    Article  Google Scholar 

  3. Elion GB, Furman PA, Fyfe JA et al (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74:5716–5720

    Article  Google Scholar 

  4. Fyfe JA, Keller PM, Furman PA et al (1978) Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl) guanine. J Biol Chem 253:8721–8727

    Google Scholar 

  5. Talwar GP, Dar SA, Rai MK et al (2008) A novel polyherbal microbiocide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int J Antimicrob Agents 32:180–185

    Article  Google Scholar 

  6. Li J, Huang Y, Guan XL et al (2012) Anti-hepatitis B virus constituents from the stem bark of Streblus asper. Phytochemistry 82:100–109

    Article  Google Scholar 

  7. Castilla V, Barquero AA, Mersich SE et al (1998) In vitro anti-Junin virus activity of a peptide isolated from Melia azedarach L. leaves. Int J Antimicrob Agents 10:67–75

    Article  Google Scholar 

  8. Chen YH, Huang PH, Lin FY et al (2011) Magnolol: a multifunction compound isolated from the Chinese medicinal plant Magnolia officinalis. Eur J Integr Med 3:e317–e324

    Article  Google Scholar 

  9. Shen Y, Zhukovskaya NL, Zimmer MI et al (2004) Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci USA 101:3242–3247

    Article  Google Scholar 

  10. Sabini E, Hazra S, Konrad M et al (2007) Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic Acids Res 35:186–192

    Article  Google Scholar 

  11. Koch K, Chen YX, Feng JY et al (2009) Nucleoside diphosphate kinase and the activation of antiviral phosphonate analogs of nucleotides: binding mode and phosphorylation of tenofovir derivatives. Nucleosides, Nucleotides Nucleic Acids 28:776–792

    Article  Google Scholar 

  12. Wynne SA, Crowther RA, Leslie AG (1999) The crystal structure of the human hepatitis B virus capsid. Mol Cell 3:771–780

    Article  Google Scholar 

  13. Garcia-Saez I, Lacroix FB, Blot D et al (2011) Structural characterization of HBXIP: the protein that interacts with the anti-apoptotic protein survivin and the oncogenic viral protein HBx. Mol Biol 405:331–340

    Article  Google Scholar 

  14. Singla RK, Bhat VG (2010) QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against Candida albicans. J Enzyme Inhib Med Chem 25(5):696–701

    Article  Google Scholar 

  15. Malleshappa NN, Patel HM (2011) A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: a rationale approach to anticancer drug design. J Saudi Chem Soc. doi:10.1016/j.jscs.2011.04.017

    Google Scholar 

  16. Bhuva HA, Kini SG (2010) Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitor. J Mol Graph Model 29:32–37

    Article  Google Scholar 

  17. VLifeMDS: Molecular Design Suite (2010) VLife Sciences Technologies Pvt. Ltd., Pune, India. (www.vlifesciences.com)

  18. Hazra S, Szewczak A, Ort S et al (2011) Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release. Biochemistry 50(14):2870–2880

    Article  Google Scholar 

Download references

Acknowledgments

GRIP docking was performed using VLife MDS 4.3 software funded by Science & Engineering Research Board (Department of Science & Technology), Govt. of India. Author Rajeev K. Singla is receiving PI/SERB’s Young Scientist’s Fellowship from SERB (Department of Science & Technology), Govt. of India.

Author information

Authors and Affiliations

  1. Division of Biotechnology, Netaji Subhas Institute of Technology, Azad Hind Fauz Marg, Sector-3, Dwarka, New Delhi, 110078, India

    Rajeev K. Singla

Authors
  1. Rajeev K. Singla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajeev K. Singla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singla, R.K. Mechanistic Evidence to Support the Anti-hepatitis B Viral Activity of Multifunctional Scaffold & Conformationally Restricted Magnolol. Natl. Acad. Sci. Lett. 37, 45–50 (2014). https://doi.org/10.1007/s40009-013-0195-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40009-013-0195-2

Keywords

Search

Navigation